Palumbo Wealth Management LLC Exagen Inc. Transaction History
Palumbo Wealth Management LLC
- $289 Million
- Q1 2025
A detailed history of Palumbo Wealth Management LLC transactions in Exagen Inc. stock. As of the latest transaction made, Palumbo Wealth Management LLC holds 99,205 shares of XGN stock, worth $582,333. This represents 0.12% of its overall portfolio holdings.
Number of Shares
99,205
Previous 86,704
14.42%
Holding current value
$582,333
Previous $355,000
0.28%
% of portfolio
0.12%
Previous 0.14%
Shares
5 transactions
Others Institutions Holding XGN
# of Institutions
39Shares Held
6.16MCall Options Held
3.4KPut Options Held
18.4K-
Rtw Investments, LP New York, NY1.51MShares$8.87 Million0.09% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$5.23 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY532KShares$3.12 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$2.88 Million0.0% of portfolio
-
Morgan Stanley New York, NY486KShares$2.85 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $95.4M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...